(NUVB) Nuvation Bio - Performance -38.3% in 12m
NUVB performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-79.29%
#127 in Peer-Group
Rel. Strength
14.69%
#6326 in Stock-Universe
Total Return 12m
-38.29%
#105 in Peer-Group
Total Return 5y
-80.50%
#91 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.83 USD |
| 52 Week Low | 1.66 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 34.77 |
| Buy/Sell Signal +-5 | -0.77 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: NUVB (-38.3%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: NUVB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NUVB
| Total Return (including Dividends) | NUVB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -16.67% | 2.09% | 4.55% |
| 3 Months | 10.80% | 2.27% | 10.78% |
| 12 Months | -38.29% | -10.84% | 14.71% |
| 5 Years | -80.50% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | NUVB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -58.4% | 18.8% | 79.2% |
| 3 Months | 27% | 71.5% | 92.9% |
| 12 Months | -78.5% | -84.3% | 44.2% |
| 5 Years | -70.8% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th11.00 | -18.37% | -20.29% |
| 3 Month | %th62.00 | 8.34% | 0.01% |
| 12 Month | %th48.00 | -30.79% | -46.20% |
| 5 Years | %th55.00 | -74.52% | -89.92% |
FAQs
Does Nuvation Bio (NUVB) outperform the market?
No,
over the last 12 months NUVB made -38.29%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months NUVB made 10.80%, while XBI made 2.27%.
Performance Comparison NUVB vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NUVB vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -6.9% | -21.2% | -32.7% | -53% |
| US NASDAQ 100 | QQQ | -7.7% | -22.2% | -34.9% | -53% |
| German DAX 40 | DAX | -6.7% | -16.7% | -45.7% | -68% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -6.6% | -20.8% | -30.7% | -56% |
| Hongkong Hang Seng | HSI | -6.5% | -22.5% | -48.5% | -74% |
| India NIFTY 50 | INDA | -6.5% | -18.8% | -32.5% | -38% |
| Brasil Bovespa | EWZ | -8.2% | -24.4% | -57.2% | -52% |
NUVB vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -8.4% | -23.4% | -39.4% | -67% |
| Consumer Discretionary | XLY | -5.3% | -18.3% | -24% | -58% |
| Consumer Staples | XLP | -3.4% | -15% | -31% | -47% |
| Energy | XLE | -2.5% | -20.2% | -27.3% | -34% |
| Financial | XLF | -7% | -19.8% | -35.8% | -67% |
| Health Care | XLV | -5.9% | -18.7% | -25.5% | -33% |
| Industrial | XLI | -6.5% | -20.4% | -39.3% | -62% |
| Materials | XLB | -4.9% | -18.3% | -32.1% | -41% |
| Real Estate | XLRE | -2.4% | -16.7% | -30.1% | -51% |
| Technology | XLK | -8.2% | -25.6% | -36% | -50% |
| Utilities | XLU | -4.5% | -16.7% | -36.1% | -63% |
| Aerospace & Defense | XAR | -8.8% | -26.5% | -54.1% | -91% |
| Biotech | XBI | -4.7% | -18.8% | -18.8% | -27% |
| Homebuilder | XHB | -5.1% | -22.8% | -21.5% | -39% |
| Retail | XRT | -3.8% | -18.1% | -24% | -44% |
NUVB vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.4% | -21.8% | -23.5% | -28% |
| Natural Gas | UNG | 5.3% | -7.2% | -17.6% | -31% |
| Gold | GLD | -1.9% | -14.5% | -52.6% | -80% |
| Silver | SLV | -3.5% | -20.5% | -51.3% | -60% |
| Copper | CPER | -7.2% | -20.9% | -52.5% | -54% |
NUVB vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -5.7% | -20.3% | -29.6% | -40% |
| iShares High Yield Corp. Bond | HYG | -4.8% | -18.5% | -31.7% | -49% |